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Summary 
A polyol-pathway related perturbation of myo-inositol metabolism has been invoked in the pathogenesis 
of diabetic complications, including retinal microvasculopathy. Previous studies have demonstrated a 
beneficiary effect of aldose reductase inhibition on basement membrane thickening of retinal microvessels 
in diabetic animals. In the present study we demonstrate a significant but partial effect on basement 
membrane thickening following myo-inositol supplementation. Qualitative structural changes, such as 
nodular swellings, fibrillar changes and basement membrane projections were not effected by myo-inositol 
supplementation, suggesting that although abnormal myo-inositol tissue levels may play a role in basement 
membrane thickening, other factors may be of primary pathogenetic importance. 
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Introduction 
Metabolic derangements secondary to hypergly- 
cemia, such as activation of the polyol-pathway 
and the associated decrease in tissue myo-inositol 
(MI) levels have been suggested as major patho- 
genetic factors in the development of secondary 
complications in diabetes [ 1,2]. The key enzyme 
in the polyol-pathway, aldose reductase, is pre- 
sent in retinal endothelial cells and pericytes [3] 
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and shows a 3-fold increase in gene expression in 
the retina of diabetic BB/W-rats [4]. The demon- 
stration of elevated sorbitol and decreased myo- 
inositol levels in association with increased 
vascular permeability in the retina of diabetic 
rodents, as well as the responsiveness of vascular 
damage to aldose-reductase inhibition or myo- 
inositol supplementation lend further support to 
the polyol-pathway/m_ro-inositol theory [ $61. We 
have previously demonstrated a complete pre- 
vention of basement membrane thickening 
(BMT) in the deep capillary bed of the diabetic 
BB/W-rat retina following 6 months of aldose re- 
ductase inhibitor (ARI)-treatment. Vigorous in- 
sulin-treatment for the same duration prevented 
14 
BMT in both the superficial and deep capillary 
beds [7] suggesting that proposed mechanisms 
such as an augmented polyol-pathway [ 8,9], non- 
enzymatic glycation [lo], or decreased produc- 
tion of specific proteoglycans [ 111, may be modi- 
fied by topographic differences [7]. 
In the present study we examined the effect of 
myo-inositol supplementation on BMT, in order 
to explore as to whether the effect of ARI-treat- 
ment on BMT is mediated by a normalization of 
the m_vc-inositol metabolism, or if this effect is a 
consequence of the sorbitol lowering effect. 
Materials and Methods 
Animals 
Pre-diabetic male BB/W-rats and age-matched 
non-diabetes-prone male BB/W-rats were ob- 
tained from the NIH-Colony at the University of 
Massachusetts, Worcester, MA. To ascertain 
onset of diabetes, diabetes-prone animals were 
monitored daily with respect to glucosuria (Test 
Tape, Eli Lilly Canada, Inc., Toronto, Ont). After 
detection of glucosuria diabetic rats were started 
on small daily doses (0.5-3.0 p/day) of protamine 
zink insulin (PZI) (Connaught-Novo Inc. 
Toronto, Ont.). Three weeks after onset of 
diabetes, the rats were randomly assigned as 
follows : non-diabetic control rats, n = 5 ; diabetic 
insulin-deficient rats maintained on small doses 
of PZI, n = 5; and diabetic insulin-deficient rats 
maintained on PZI and fed a 17; myo-inositol 
supplemented diet, n = 5. All animals were 
maintained in individual air-filtered metabolic 
cages with free access to rat-chow (non-MI- 
supplemented chow contained 0.05% MI) (Lab 
Blox F-6, Wayne Animal Diets, Winnipeg, MB, 
Canada) and water. Blood glucose levels were 
examined every second week and glycated hemo- 
globin every 3 months as previously described 
[ 71. Five animals from each group were sacrificed 
after 6 months of diabetes. 
Tissue collectiorl 
Animals were anesthetized with pentobarbital 
sodium (50 mg/kg body weight) and perfused with 
2.5”; glutaraldehyde in cacodylate buffer 
(pH 7.4). Retinal segments within 3 mm of the 
optic nerve head were taken from the superior 
temporal quadrant. The tissues were processed 
and examined electron microscopically as pre- 
viously described [ 71. 
Morphorvetric examination 
Twenty cross-sectioned capillaries, 10 from the 
superficial capillary bed and 10 from the deep 
capillary bed, were examined in each animal. 
Capillary basement thickness, pericyte and endo- 
thelial cell profile areas and lumenal areas (ex- 
pressed as percentages of total capillary area), 
and number of pericyte profiles and endothelial 
cells per capillary were calculated as previously 
described in detail [ 121. 
Each capillary was examined for the presence 
of basement membrane abnormalities (nodular 
swellings, laminated basement membranes, and 
fibrillary material, [ 7]), and basement membrane 
projections. These changes were expressed as a 
percentage of capillaries showing the abnor- 
malities. The mean value of basement membrane 
abnormalities was obtained in each capillary bed 
in individual animals. The investigator (S.C.) was 
unaware of the identity of the tissue samples. 
Statistical anai_s.si.s 
The data are expressed as mean f SEM. One 
way analysis of variance with linear contrast, and 




MI-treated and untreated diabetic rats showed 
significantly lower body weights (P < 0.001) 
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compared to non-diabetic control rats (392.0 k 
16.6 and 382.4 k 12.4 vs 497.0 2 6.5 g respec- 
tively). They showed elevated blood glucose levels 
(P < 0.002) (22.0 k 2.1 and 20.8 k 2.1 vs 8.1 
& 1.3 mmol/l, respectively) and increased gly- 
cated hemoglobin levels (P < 0.002) (9.7 + 
0.9 and 10.9 k 1.6 vs 3.9 & O.l%, respectively). 
Vascular morphometry 
In control as well as diabetic animals the BMT of 
the superficial capillaries was greater than that of 
the deep capillaries. MI-treatment showed a sig- 
nificant (P < 0.001) but only partial prevention of 
BMT of the deep capillaries, and had no effect on 
BMT in superficial capillaries. Structural base- 
ment membrane abnormalities were not pre- 
vented by MI-treatment nor did this regimen have 
an effect on basement membrane projections 
(Table 1). Endothelial cell and pericyte mor- 
phometry was not altered by diabetes or MI-treat- 
ment (data not shown). Regression analysis of 
BMT with blood glucose concentrations and gly- 
cated hemoglobin levels as independent variables 
TABLE 1 
revealed significant positive relationships for both 
capillary beds (Fig. 1). 
Discussion 
The mechanisms responsible for basement 
membrane thickening in diabetes remain obscure. 
The only hard evidence at hand is that hypergly- 
cemia is somehow required for the accelerated 
basement membrane thickening as substantiated 
by the data in the present study. The possibility 
that this adverse effect of hyperglycemia may at 
least in part be mediated by an increased activity 
of the polyol-pathway, is supported by a similar 
thickening of the retinal capillary basement 
membranes in galactosemic animals, that is 
prevented by aldose reductase inhibition [ 81. We 
[7] and others [ 131 have previously reported that 
inhibition of the polyol-pathway prevents the 
BMT in diabetic rats. However, this preventive 
effect does not appear to be universal, since in our 
previous study [7] a complete inhibition was 
achieved only in the deep capillaries of the retina 
Basement membrane thickness (BMT), basement membrane (BM) abnormalities and projections in control, diabetic and 
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Fig. I. Regression analysis of retinal capillary BM thickness 
with (top) blood glucose levels as the independent variable 
(r = 0.8, P < 0.001 for superficial and r = 0.75, P < 0.005 for 
deep capillary bed) and (bottom) glycated Hb levels as the 
independent variable (v = 0.75, P < 0.005 for superficial and 
Y = 0.78, P < 0.001 for deep capillary bed). 
but not in the superficial capillaries, despite 
similar immunoreactivity in the two capillary beds 
[3]. These findings suggest, if indeed the polyol- 
pathway activation and subsequent metabolic 
abnormalities play a major role in BMT, that the 
activity of the rate limiting enzyme aldose reduc- 
tase, or its enzyme kinetics may vary greatly from 
one capillary bed to another. The failure of an 
AR1 to show an effect on skeletal muscle capillary 
basement membrane in diabetic subjects would 
seem to support this notion [ 141. 
In the present study MI-supplementation had 
a significant but only partial preventive effect on 
BMT in the deep capillary bed of the diabetic 
retina in the BB/W-rat. This would indicate that 
at least part of the complete prevention achieved 
following ARI-treatment in the same capillary bed 
is mediated by an effect of the polyol-pathway on 
MI-metabolism, or alternatively that a 1% MI- 
supplementation was insufficient to normalize the 
MI pool. The latter explanation is unlikely, how- 
ever, since Tilton et al. 
strated a non-significant 
the deep capillary bed 
following 9 months of a 
diet. 
[ 151 recently demon- 
prevention of BMT in 
of STZ-diabetic rats 
2% MI supplemented 
The positive relationship between blood-glu- 
cose levels and BMT in both diabetic rodents [ 71 
and man [ 141, may suggest that non-enzymatic 
linkage between extracellular matrix proteins and 
various hexoses could be mainly responsible for 
BMT, as suggested by Brownlee et al. [lo]. 
This notion is in keeping with our previous 
suggestion that the demonstrated effect of AR1 on 
BMT [7] may be mediated by a diminished pro- 
duction of fructose by the polyol-pathway, since 
it has been demonstrated that fructose is a potent 
glycator of structural proteins [ 161. 
In summary, the present study has demon- 
strated a significant effect of myo-inositol supple- 
mentation on BMT in the diabetic BB/W-rat 
retina. However, the exact mechanism by which 
this is achieved remains to be investigated. 
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